POP Pharma SRL
The score of POP Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
POP Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 27 Sep 2022
POP Pharma's financial analysis
- Solvency84.2%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of POP Pharma
POP Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0831.101.641
- VAT number
- BE0831101641
- Peppol
- Registered · 0208:0831101641 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Nov 2010
- Registered office
- 1741 Ternat
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
POP Pharma (SRL) has been based in Ternat since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 269,974 € and equity of 962,646 €; its revenue is not published. Its solvency stands at 84.2%, above the median of its sector (44.0%).
Companies similar to POP Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Deltaphar Retail sale of pharmaceutical products Auderghem · balance sheet €1.14m
- Chaspierre Holding Retail sale of pharmaceutical products Verviers · balance sheet €1.13m
- Bouckaert - Mekeirele Retail sale of pharmaceutical products Zedelgem · balance sheet €1.25m
- Apotheek Bruggeman Retail sale of pharmaceutical products Ghent · balance sheet €1.17m
- Farma Noord Retail sale of pharmaceutical products Kalmthout · balance sheet €1.12m
- Novaka Pharma Retail sale of pharmaceutical products Nivelles · balance sheet €1.10m
- Apoteek Mommaert Retail sale of pharmaceutical products Beersel · balance sheet €1.09m
Frequently asked questions about POP Pharma
What is the revenue of POP Pharma?
POP Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of POP Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0831101641 for POP Pharma, if the company is VAT-registered. Its company number (CBE) is 0831.101.641.
Where is the registered office of POP Pharma?
According to the CBE register, the registered office of POP Pharma is in 1741 Ternat.
What is the equity of POP Pharma?
At the close of the 2025 financial year, the equity of POP Pharma amounts to 962,646 €, a solvency of 84.2% of total assets.
Who manages POP Pharma?
The register lists 2 active mandates at POP Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of POP Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →